Find in Library

The spectrum of COVID-19 continues to evolve, uncovering several manifestations with every passing day. One of the complications is multisystem inflammatory syndrome (MIS) that occurs both in children and adults. MIS in children (MIS-C) has become a recognized syndrome, whereas a parallel syndrome in adults (MIS in adults [MIS-A]) has not been yet well defined. Due to the overlap between COVID 19 and MIS-A, we tend to miss cases of MIS-A. In this review, we have focused on MIS-A, its diagnostic criteria, pathogenesis, treatment, its relationship with vaccination, and differentiation from COVID 19.